Trial Profile
Thalidomide Treatment for Crow Fukase (POEMS) Syndrome: A Multicenter, Randomized, Double blind, Placebo controlled, Parallel group Trial with an Extension Phase to Evaluate the Long term Safety
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 16 Jun 2017
Price :
$35
*
At a glance
- Drugs Thalidomide (Primary)
- Indications POEMS syndrome
- Focus Therapeutic Use
- Acronyms J-POST
- 16 Jun 2017 New trial record